Advisory Resource Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Buy |
1,928
+12
| +0.6% | +$2.23K | 0.07% | 140 |
|
|
2025
Q1 | $401K | Buy |
1,916
+12
| +0.6% | +$2.51K | 0.08% | 136 |
|
|
2024
Q4 | $338K | Buy |
1,904
+56
| +3% | +$9.95K | 0.07% | 136 |
|
|
2024
Q3 | $365K | Sell |
1,848
-39
| -2% | -$7.7K | 0.08% | 129 |
|
|
2024
Q2 | $324K | Sell |
1,887
-88
| -4% | -$15.1K | 0.07% | 128 |
|
|
2024
Q1 | $360K | Buy |
1,975
+11
| +0.6% | +$2K | 0.08% | 128 |
|
|
2023
Q4 | $304K | Buy |
1,964
+14
| +0.7% | +$2.17K | 0.08% | 131 |
|
|
2023
Q3 | $291K | Sell |
1,950
-223
| -10% | -$33.2K | 0.08% | 130 |
|
|
2023
Q2 | $293K | Sell |
2,173
-243
| -10% | -$32.7K | 0.08% | 128 |
|
|
2023
Q1 | $385K | Buy |
2,416
+49
| +2% | +$7.81K | 0.11% | 123 |
|
|
2022
Q4 | $383K | Buy |
2,367
+11
| +0.5% | +$1.78K | 0.11% | 120 |
|
|
2022
Q3 | $316K | Buy |
2,356
+12
| +0.5% | +$1.61K | 0.1% | 102 |
|
|
2022
Q2 | $359K | Buy |
2,344
+11
| +0.5% | +$1.69K | 0.12% | 90 |
|
|
2022
Q1 | $378K | Buy |
2,333
+11
| +0.5% | +$1.78K | 0.12% | 97 |
|
|
2021
Q4 | $318K | Sell |
2,322
-37
| -2% | -$5.07K | 0.11% | 106 |
|
|
2021
Q3 | $254K | Buy |
2,359
+10
| +0.4% | +$1.08K | 0.09% | 116 |
|
|
2021
Q2 | $265K | Buy |
2,349
+11
| +0.5% | +$1.24K | 0.11% | 111 |
|
|
2021
Q1 | $253K | Buy |
2,338
+11
| +0.5% | +$1.19K | 0.12% | 87 |
|
|
2020
Q4 | $249K | Buy |
2,327
+11
| +0.5% | +$1.18K | 0.12% | 84 |
|
|
2020
Q3 | $203K | Buy |
2,316
+34
| +1% | +$2.98K | 0.12% | 90 |
|
|
2020
Q2 | $224K | Buy |
+2,282
| New | +$224K | 0.14% | 77 |
|